Subject
Cell Biology,Clinical Biochemistry,Biochemistry,General Medicine,Analytical Chemistry
Reference17 articles.
1. Characterization of meta-iodobenzylguanidine (mIBG) transport by polyspecific organic cation transporters: Implication for mIBG therapy;Quiñones;Mol. Pharmacol.,2020
2. Nothing but NET: a review of norepinephrine transporter expression and efficacy of 131I-mIBG therapy, Pediatr. Blood;Streby;Cancer,2015
3. Radiation dosimetry, pharmacokinetics, and safety of ultratraceTM iobenguane I-131 in patients with malignant pheochromocytoma/paraganglioma or metastatic carcinoid;Coleman;Cancer Biother. Radiopharm.,2009
4. Phase-1 clinical trial results of high-specific-activity carrier-free 123I-iobenguane;Chin;J. Nucl. Med.,2014
5. K.M. Huang, M. Zavorka Thomas, T. Magdy, E.D. Eisenmann, M.E. Uddin, D.F. DiGiacomo, A. Pan, M. Keiser, M. Otter, S.H. Xia, Y. Li, Y. Jin, Q. Fu, A.A. Gibson, I.M. Bonilla, C.A. Carnes, K.N. Corps, V. Coppola, S.A. Smith, D. Addison, A.T. Nies, R. Bundschuh, T. Chen, M.B. Lustberg, J. Wang, S. Oswald, M.J. Campbell, P.S. Yan, S.D. Baker, S. Hu, P.W. Burridge, A. Sparreboom, Targeting OCT3 attenuates doxorubicin-induced cardiac injury., Proc. Natl. Acad. Sci. U. S. A. 118 (2021). https://doi.org/10.1073/pnas.2020168118.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献